Counterfeit pharmaceutical drugs are a rising risk to Canadians as they’re appearing in brick-and-mortar pharmacies, rather than just on the street or online, according to a new report by public policy think tank the Fraser Institute.
It’s also a growing issue internationally and one that’s attracting the attention of policy-makers. But what does it mean for group benefits plans?
Counterfeit drugs can increase plan costs by harming…
OR FIND OUT